Regulation of Podocyte Actin Cytoskeleton

足细胞肌动蛋白细胞骨架的调节

基本信息

  • 批准号:
    8290587
  • 负责人:
  • 金额:
    $ 15.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-15 至 2013-09-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): End stage renal disease (ESRD) is an important public health issue. Based on 2005 USRDS data ESRD patients utilize 19.2 percent of medicare spending (21.3 billion dollars). Diabetic nephropathy and glomerulonephritis contributes about 56.5 percent of the incident patients on dialysis. Glomerulus is the filtering unit of the kidney. Podocytes are morphologically unique cells, which have octopus-like processes (foot processes) which interdigitate to form the slit diaphragm. Most glomerular diseases present with proteinuria and podocyte foot process effacement. Our lab has identified signaling mechanisms employed by slit diaphragm proteins to regulate the actin cytoskeleton of the podocyte. These signaling mechanisms appear to be essential for maintaining the unique structure and function of this cell. Human mutations of several of these gene products such as Nephrin, Podocin, and alpha actinin-4 lead to foot process effacement and proteinuria and result in scarring of the kidney causing renal failure and eventually end stage renal disease requiring dialysis. The guiding hypothesis of this application is that the slit diaphragm protein complex regulates podocyte actin cytoskeletal dynamics. Based on our preliminary work, this project will focus on several aspects of this mechanism. Specifically we will: (1) Investigate signaling mechanisms by which Nephrin and Neph1 cooperate in actin polymerization. Our preliminary data suggests a role for nWASP and cortactin in Nephrin/Neph1 mediated actin polymerization. These proteins are known to assemble, promote, regulate and stabilize the actin polymerization complex. Using biochemical and cell biological techniques we will characterize the interaction of these two proteins with Nephrin and Neph1. (2) Investigate the role of cofilin in podocyte actin cytoskeletal dynamics. Our preliminary data shows a signaling relationship between Nephrin and cofilin. Cofilin is necessary for actin polymerization and remodeling. 3. To further characterize the physiological role of cofilin in podocytes in development and in podocyte injury, we will engineer and phenotye mice deleted of cofilin in a podocyte-specific fashion.
描述(由申请人提供): 终末期肾病(ESRD)是一个重要的公共卫生问题。根据 2005 年 USRDS 数据,ESRD 患者使用了 19.2% 的医疗保险支出(213 亿美元)。糖尿病肾病和肾小球肾炎约占透析患者的 56.5%。肾小球是肾脏的过滤单位。足细胞是形态独特的细胞,具有章鱼样突起(足突),相互交叉形成裂隙隔膜。大多数肾小球疾病表现为蛋白尿和足细胞足突消失。我们的实验室已经确定了缝隙隔膜蛋白用于调节足细胞肌动蛋白细胞骨架的信号机制。这些信号传导机制似乎对于维持该细胞的独特结构和功能至关重要。其中几种基因产物(如 Nephrin、Podocin 和 α actinin-4)的人类突变会导致足突消失和蛋白尿,并导致肾脏疤痕,导致肾功能衰竭,最终导致需要透析的终末期肾病。该应用的指导假设是裂隙隔膜蛋白复合物调节足细胞肌动蛋白细胞骨架动力学。根据我们的前期工作,该项目将重点关注该机制的几个方面。具体来说,我们将: (1) 研究 Nephrin 和 Neph1 在肌动蛋白聚合中合作的信号机制。我们的初步数据表明 nWASP 和 cortactin 在 Nephrin/Neph1 介导的肌动蛋白聚合中发挥作用。已知这些蛋白质可以组装、促进、调节和稳定肌动蛋白聚合复合物。使用生化和细胞生物学技术,我们将表征这两种蛋白质与 Nephrin 和 Neph1 的相互作用。 (2)研究cofilin在足细胞肌动蛋白细胞骨架动力学中的作用。我们的初步数据显示了 Nephrin 和 cofilin 之间的信号传导关系。 Cofilin 是肌动蛋白聚合和重塑所必需的。 3. 为了进一步表征肌丝蛋白丝切蛋白在足细胞发育和足细胞损伤中的生理作用,我们将以足细胞特异性方式设计和表达删除肌丝蛋白丝切蛋白的小鼠。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PUNEET GARG其他文献

PUNEET GARG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PUNEET GARG', 18)}}的其他基金

Shp2 a Non-Receptor Tyrosine Phosphatase Regulates Nephrin Phosphorylation and Po
Shp2 非受体酪氨酸磷酸酶调节去氧肾上腺素磷酸化和 Po
  • 批准号:
    9199082
  • 财政年份:
    2014
  • 资助金额:
    $ 15.5万
  • 项目类别:
Shp2 a Non-Receptor Tyrosine Phosphatase Regulates Nephrin Phosphorylation and Po
Shp2 非受体酪氨酸磷酸酶调节去氧肾上腺素磷酸化和 Po
  • 批准号:
    8785120
  • 财政年份:
    2014
  • 资助金额:
    $ 15.5万
  • 项目类别:
Shp2 a Non-Receptor Tyrosine Phosphatase Regulates Nephrin Phosphorylation and Po
Shp2 非受体酪氨酸磷酸酶调节去氧肾上腺素磷酸化和 Po
  • 批准号:
    8995200
  • 财政年份:
    2014
  • 资助金额:
    $ 15.5万
  • 项目类别:
Shp2 a Non-Receptor Tyrosine Phosphatase Regulates Nephrin Phosphorylation and Po
Shp2 非受体酪氨酸磷酸酶调节去氧肾上腺素磷酸化和 Po
  • 批准号:
    8629068
  • 财政年份:
    2014
  • 资助金额:
    $ 15.5万
  • 项目类别:
Role of Endocytosis and Vesicular Trafficking in Podocyte Health and Filter Integ
内吞作用和囊泡运输在足细胞健康和过滤器完整性中的作用
  • 批准号:
    8355212
  • 财政年份:
    2012
  • 资助金额:
    $ 15.5万
  • 项目类别:
Regulation of Podocyte Actin Cytoskeleton
足细胞肌动蛋白细胞骨架的调节
  • 批准号:
    7994909
  • 财政年份:
    2010
  • 资助金额:
    $ 15.5万
  • 项目类别:
Regulation of Podocyte Actin Cytoskeleton
足细胞肌动蛋白细胞骨架的调节
  • 批准号:
    7509978
  • 财政年份:
    2008
  • 资助金额:
    $ 15.5万
  • 项目类别:
Regulation of Podocyte Actin Cytoskeleton
足细胞肌动蛋白细胞骨架的调节
  • 批准号:
    7658745
  • 财政年份:
    2008
  • 资助金额:
    $ 15.5万
  • 项目类别:
Regulation of Podocyte Actin Cytoskeleton
足细胞肌动蛋白细胞骨架的调节
  • 批准号:
    7892559
  • 财政年份:
    2008
  • 资助金额:
    $ 15.5万
  • 项目类别:
Regulation of Podocyte Actin Cytoskeleton
足细胞肌动蛋白细胞骨架的调节
  • 批准号:
    8110555
  • 财政年份:
    2008
  • 资助金额:
    $ 15.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 15.5万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 15.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了